Barbara Obermayer-Pietsch
Overview
Explore the profile of Barbara Obermayer-Pietsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
213
Citations
5486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trummer O, Laglstorfer C, Haudum C, Missbrenner C, Goessler W, Obermayer-Pietsch B, et al.
Environ Toxicol Pharmacol
. 2025 Feb;
115:104662.
PMID: 40010557
We previously identified the trimethylsulfonium ion (TMS) in human urine and highlighted its potential as a novel HS biomarker but observed significant inter-individual variability in its urinary excretion. In this...
2.
Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX
Kanis J, Johansson H, McCloskey E, Liu E, Schini M, Vandenput L, et al.
Osteoporos Int
. 2025 Feb;
PMID: 39955689
Introduction: RA is a well-documented risk factor for subsequent fracture that is incorporated into the FRAX algorithm. The aim of this study was to evaluate, in an international meta-analysis, the...
3.
Cejka V, Riepl H, Schwegel N, Kolesnik E, Zach D, Santner V, et al.
ESC Heart Fail
. 2025 Feb;
PMID: 39904947
Aims: Heart failure (HF) impairs skeletal muscle mass and function, which contributes to reduced physical performance. We investigated the prognostic impact of gait speed (GS), handgrip strength (HG) and appendicular...
4.
Theiler-Schwetz V, Trummer C, Schmitt L, Terbuch A, Obermayer-Pietsch B, Richtig E, et al.
Ann Med
. 2025 Jan;
57(1):2453829.
PMID: 39862267
Objective: One of the most severe endocrine side effects of immune checkpoint inhibitors (ICI) is hypophysitis leading to adrenal insufficiency. Recovery is rare, although it has been reported after high-dose...
5.
Trummer O, Stern C, Reintar S, Mayer-Pickel K, Cervar-Zivkovic M, Dischinger U, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684415
Steroid hormone imbalance is associated with the pathogenesis of preeclampsia. However, affected enzymes of steroid metabolism and gene and protein expression in serum and placenta have not been elucidated yet....
6.
Eissa T, Huber M, Obermayer-Pietsch B, Linkohr B, Peters A, Fleischmann F, et al.
PNAS Nexus
. 2024 Oct;
3(10):pgae449.
PMID: 39440022
Molecular analytics increasingly utilize machine learning (ML) for predictive modeling based on data acquired through molecular profiling technologies. However, developing robust models that accurately capture physiological phenotypes is challenged by...
7.
Livadas S, Yildiz B, Mastorakos G, Gambineri A, Pignatelli D, Giorgino F, et al.
Eur J Endocrinol
. 2024 Aug;
191(2):134-143.
PMID: 39099229
Background: Although polycystic ovary syndrome (PCOS) is a very common endocrinopathy, there are several issues related to this disorder which perplex clinicians in their everyday practice. Objective: To determine the...
8.
Gil-Redondo R, Conde R, Bruzzone C, Seco M, Bizkarguenaga M, Gonzalez-Valle B, et al.
Cardiovasc Diabetol
. 2024 Jul;
23(1):272.
PMID: 39048982
Background: Metabolic syndrome (MetS) is a cluster of medical conditions and risk factors correlating with insulin resistance that increase the risk of developing cardiometabolic health problems. The specific criteria for...
9.
Khashayar P, Lopes P, Ragaert P, Hoogenboom R, Latta D, Gransee R, et al.
Anal Methods
. 2024 May;
16(21):3337-3348.
PMID: 38738371
Despite the increasing efforts in improving bone health assessments, current diagnostics suffer from critical shortcomings. The present article therefore describes a multiplex label-free immunosensor designed and validated for the assessment...
10.
Trummer C, Pandis M, Theiler-Schwetz V, Schmitt L, Obermayer-Pietsch B, Gellner V, et al.
Endocrine
. 2024 Apr;
85(2):926-936.
PMID: 38647982
Purpose: Surgical therapy represents the first-line treatment for endogenous Cushing's syndrome (CS). While postoperative glucocorticoid replacement is mandatory after surgical remission, the role of perioperative glucocorticoid therapy is unclear. Methods:...